Antibodies are essential to tackling many viral diseases, but taking them from discovery to use in the field often requires a significant amount of time and investment. Through the Pandemic Protection Platform program, scientists are using an accelerated process that bypasses much of the cell-based work of standard development approaches, aiming to provide access to treatments within 60 days.

Download this app note to discover how scientists are fighting in a race against time to speed up the development of anti-viral antibodies, by applying a method that uses:

• Affordable synthetic DNA 
• High throughput platforms
• A workflow that can produce material for screening in days